Search research articles
Contact Us
Filters
Showing results (81-90 of 140) with videos related to
Page
of 14
Sort By:
Hybridoma
|
January 1, 1986
123I radiolabeling of monoclonal antibodies for in vivo procedures
S L Mills, S J Denardo, G L Denardo, et al.
Protein Engineering
|
December 1, 1987
Expression in COS cells of a mouse-human chimaeric B72.3 antibody
N Whittle, J Adair, C Lloyd, et al.
Journal of Biochemistry
|
May 2, 2000
Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization
A Goel, G W Beresford, D Colcher, et al.
Diseases of the Colon and Rectum
|
September 1, 1987
Immunoscintigraphy in the follow-up of patients operated on for carcinoma of the sigmoid and rectum. Preliminary report with a new monoclonal antibody: B72.3
A Renda, M Salvatore, M Sava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial
M Tempero, P Leichner, G Dalrymple, et al.
The Journal of Laboratory and Clinical Medicine
|
March 1, 1987
Modulation of human tumor antigen expression
J W Greiner, P H Hand, D Colcher, et al.
Journal of the National Cancer Institute
|
May 2, 1990
Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy
J Schlom, A Molinolo, J F Simpson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1987
New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts
J M Esteban, J Schlom, O A Gansow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial
M Tempero, P Leichner, J Baranowska-Kortylewicz, et al.
International Journal of Cancer
|
September 15, 1988
Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: comparison of in vivo gamma probe counts with in vitro MAb radiolocalization
S E Tuttle, S D Jewell, C M Mojzisik, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 140) with videos related to
Sort By:
Page
of 14
Hybridoma
|
January 1, 1986
123I radiolabeling of monoclonal antibodies for in vivo procedures
S L Mills, S J Denardo, G L Denardo, et al.
Protein Engineering
|
December 1, 1987
Expression in COS cells of a mouse-human chimaeric B72.3 antibody
N Whittle, J Adair, C Lloyd, et al.
Journal of Biochemistry
|
May 2, 2000
Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization
A Goel, G W Beresford, D Colcher, et al.
Diseases of the Colon and Rectum
|
September 1, 1987
Immunoscintigraphy in the follow-up of patients operated on for carcinoma of the sigmoid and rectum. Preliminary report with a new monoclonal antibody: B72.3
A Renda, M Salvatore, M Sava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial
M Tempero, P Leichner, G Dalrymple, et al.
The Journal of Laboratory and Clinical Medicine
|
March 1, 1987
Modulation of human tumor antigen expression
J W Greiner, P H Hand, D Colcher, et al.
Journal of the National Cancer Institute
|
May 2, 1990
Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy
J Schlom, A Molinolo, J F Simpson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1987
New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts
J M Esteban, J Schlom, O A Gansow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial
M Tempero, P Leichner, J Baranowska-Kortylewicz, et al.
International Journal of Cancer
|
September 15, 1988
Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: comparison of in vivo gamma probe counts with in vitro MAb radiolocalization
S E Tuttle, S D Jewell, C M Mojzisik, et al.
Page
of 14